Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.

× No keyword cloud information.

79 in total

1. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors: Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal: Nat Protoc Date: 2010-06-03 Impact factor: 13.491

2. Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors: W Sue T Griffin; Steven W Barger
Journal: US Neurol Date: 2010

3. Spinal cord vascular and leptomeningeal amyloid beta-protein deposition in a case with cerebral amyloid angiopathy.

Authors: T Tokuda; S Ikeda; K Maruyama; N Yanagisawa; N Ito
Journal: Acta Neuropathol Date: 1992 Impact factor: 17.088

4. N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity.

Authors: Joel Lindgren; Anna Wahlström; Jens Danielsson; Natalia Markova; Caroline Ekblad; Astrid Gräslund; Lars Abrahmsén; Amelie Eriksson Karlström; Sebastian K T S Wärmländer
Journal: Protein Sci Date: 2010-12 Impact factor: 6.725

5. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

Authors: Joshua B Owen; Rukhsana Sultana; Christopher D Aluise; Michelle A Erickson; Tulin O Price; Guojun Bu; William A Banks; D Allan Butterfield
Journal: Free Radic Biol Med Date: 2010-10-07 Impact factor: 7.376

6. Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice.

Authors: James H Park; Gabriel A Widi; David A Gimbel; Noam Y Harel; Daniel H S Lee; Stephen M Strittmatter
Journal: J Neurosci Date: 2006-12-20 Impact factor: 6.167

7. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein.

Authors: T Tokuda; S Ikeda; N Yanagisawa; Y Ihara; G G Glenner
Journal: Acta Neuropathol Date: 1991 Impact factor: 17.088

8. Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors: Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal: J Biol Chem Date: 2015-04-27 Impact factor: 5.157

Review 9. Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease.

Authors: Khalid Iqbal; M Omar Chohan; Inge Grundke-Iqbal
Journal: J Alzheimers Dis Date: 2008-10 Impact factor: 4.472

10. Upregulation of SET expression by BACE1 and its implications in Down syndrome.

Authors: Xiaozhu Zhang; Yili Wu; Xiaoling Duan; Wei Chen; Haiyan Zou; Mingming Zhang; Shuting Zhang; Fang Cai; Weihong Song
Journal: Mol Neurobiol Date: 2014-06-17 Impact factor: 5.590